{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T09:25:34Z","timestamp":1777627534438,"version":"3.51.4"},"reference-count":69,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":2081,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1038\/modpathol.2016.232","type":"journal-article","created":{"date-parts":[[2017,1,13]],"date-time":"2017-01-13T07:44:31Z","timestamp":1484293471000},"page":"698-709","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["P-cadherin: a useful biomarker for axillary-based breast cancer decisions in the clinical practice"],"prefix":"10.1016","volume":"30","author":[{"given":"Andr\u00e9 Filipe","family":"Vieira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Rita","family":"Dion\u00edsio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madalena","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge F","family":"Cameselle-Teijeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"Lacerda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Amendoeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana","family":"Paredes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2016.232_bib1","article-title":"GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]","author":"Ferlay","year":"2013","journal-title":"International Agency for Research on Cancer"},{"key":"10.1038\/modpathol.2016.232_bib2","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.breast.2014.08.009","article-title":"ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)","volume":"23","author":"Cardoso","year":"2014","journal-title":"Breast"},{"key":"10.1038\/modpathol.2016.232_bib3","unstructured":"ESMO. The European Society of Medical Oncology, 2015 (available from http:\/\/www.esmo.org."},{"key":"10.1038\/modpathol.2016.232_bib4","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.breast.2015.02.031","article-title":"Discrepancies between ESMO and NCCN breast cancer guidelines: an appraisal","volume":"24","author":"Zagouri","year":"2015","journal-title":"Breast"},{"key":"10.1038\/modpathol.2016.232_bib5","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1158\/0008-5472.CAN-08-3441","article-title":"Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics","volume":"69","author":"Hennessy","year":"2009","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2016.232_bib6","doi-asserted-by":"crossref","first-page":"R76","DOI":"10.1186\/gb-2007-8-5-r76","article-title":"Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors","volume":"8","author":"Herschkowitz","year":"2007","journal-title":"Genome Biol"},{"key":"10.1038\/modpathol.2016.232_bib7","doi-asserted-by":"crossref","first-page":"9212","DOI":"10.1073\/pnas.96.16.9212","article-title":"Distinctive gene expression patterns in human mammary epithelial cells and breast cancers","volume":"96","author":"Perou","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/modpathol.2016.232_bib8","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"key":"10.1038\/modpathol.2016.232_bib9","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","article-title":"Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications","volume":"98","author":"Sorlie","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/modpathol.2016.232_bib10","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.1073\/pnas.0932692100","article-title":"Repeated observation of breast tumor subtypes in independent gene expression data sets","volume":"100","author":"Sorlie","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/modpathol.2016.232_bib11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1634\/theoncologist.10-90003-20","article-title":"Extending survival with chemotherapy in metastatic breast cancer","volume":"10 Suppl 3","author":"O'Shaughnessy","year":"2005","journal-title":"Oncologist"},{"key":"10.1038\/modpathol.2016.232_bib12","series-title":"Surveillance, Epidemiology, and End Results (SEER) Program Research Data (1973-2013)","year":"2016"},{"key":"10.1038\/modpathol.2016.232_bib13","doi-asserted-by":"crossref","first-page":"vii11","DOI":"10.1093\/annonc\/mds232","article-title":"Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"23 Suppl 7","author":"Cardoso","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1038\/modpathol.2016.232_bib14","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10549-006-9300-2","article-title":"Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis","volume":"101","author":"D'Andrea","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"10.1038\/modpathol.2016.232_bib15","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1200\/JCO.1989.7.9.1239","article-title":"Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years","volume":"7","author":"Rosen","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2016.232_bib16","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1200\/JCO.1994.12.10.2229","article-title":"Karnofsky Memorial Lecture. Natural history of small breast cancers","volume":"12","author":"Hellman","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2016.232_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1755-8794-1-13","article-title":"The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis","volume":"1","author":"Riker","year":"2008","journal-title":"BMC Med Genomics"},{"key":"10.1038\/modpathol.2016.232_bib18","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/iju.12183","article-title":"Expression profiling of metastatic renal cell carcinoma using gene set enrichment analysis","volume":"21","author":"Maruschke","year":"2013","journal-title":"Int J Urol"},{"key":"10.1038\/modpathol.2016.232_bib19","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1172\/JCI22320","article-title":"Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors","volume":"115","author":"Minn","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1038\/modpathol.2016.232_bib20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10585-008-9232-9","article-title":"A gene expression signature that defines breast cancer metastases","volume":"26","author":"Ellsworth","year":"2009","journal-title":"Clin Exp Metastasis"},{"key":"10.1038\/modpathol.2016.232_bib21","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/ejhg.2009.230","article-title":"Frequent genetic differences between matched primary and metastatic breast cancer provide an approach to identification of biomarkers for disease progression","volume":"18","author":"Poplawski","year":"2010","journal-title":"Eur J Hum Genet"},{"key":"10.1038\/modpathol.2016.232_bib22","doi-asserted-by":"crossref","first-page":"15901","DOI":"10.1073\/pnas.2634067100","article-title":"Gene expression profiles of primary breast tumors maintained in distant metastases","volume":"100","author":"Weigelt","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/modpathol.2016.232_bib23","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/sj.bjc.6602794","article-title":"No common denominator for breast cancer lymph node metastasis","volume":"93","author":"Weigelt","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1038\/modpathol.2016.232_bib24","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1007\/s00268-010-0499-z","article-title":"Does analysis of biomarkers in tumor cells in lymph node metastases give additional prognostic information in primary breast cancer?","volume":"34","author":"Falck","year":"2010","journal-title":"World J Surg"},{"key":"10.1038\/modpathol.2016.232_bib25","first-page":"1267","article-title":"Discordance rate of HER2 status in primary breast carcinomas versus synchronous axillary lymph node metastases: a multicenter retrospective investigation","volume":"7","author":"Ieni","year":"2014","journal-title":"Onco Targets Ther"},{"key":"10.1038\/modpathol.2016.232_bib26","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10549-011-1610-3","article-title":"ER, HER2, and TOP2A expression in primary tumor, synchronous axillary nodes, and asynchronous metastases in breast cancer","volume":"132","author":"Jensen","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1038\/modpathol.2016.232_bib27","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.clbc.2015.03.010","article-title":"Hormone receptor status and HER2 expression in primary breast cancer compared with synchronous axillary metastases or recurrent metastatic disease","volume":"15","author":"Rossi","year":"2015","journal-title":"Clin Breast Cancer"},{"key":"10.1038\/modpathol.2016.232_bib28","first-page":"5744","article-title":"Comparison of the expression of prognostic biomarkers between primary tumor and axillary lymph node metastases in breast cancer","volume":"8","author":"Zhao","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1038\/modpathol.2016.232_bib29","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.stem.2014.02.002","article-title":"Metastatic stem cells: sources, niches, and vital pathways","volume":"14","author":"Oskarsson","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1038\/modpathol.2016.232_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2014.03.036","article-title":"Breast cancer stem cells: multiple capacities in tumor metastasis","volume":"349","author":"Geng","year":"2014","journal-title":"Cancer Lett"},{"key":"10.1038\/modpathol.2016.232_bib31","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/35102167","article-title":"Stem cells, cancer, and cancer stem cells","volume":"414","author":"Reya","year":"2001","journal-title":"Nature"},{"key":"10.1038\/modpathol.2016.232_bib32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrm1004","article-title":"CD44: from adhesion molecules to signalling regulators","volume":"4","author":"Ponta","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1038\/modpathol.2016.232_bib33","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","article-title":"Prospective identification of tumorigenic breast cancer cells","volume":"100","author":"Al-Hajj","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/modpathol.2016.232_bib34","doi-asserted-by":"crossref","first-page":"10946","DOI":"10.1158\/0008-5472.CAN-05-2018","article-title":"Prospective identification of tumorigenic prostate cancer stem cells","volume":"65","author":"Collins","year":"2005","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2016.232_bib35","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1158\/0008-5472.CAN-06-2030","article-title":"Identification of pancreatic cancer stem cells","volume":"67","author":"Li","year":"2007","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2016.232_bib36","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature05372","article-title":"A human colon cancer cell capable of initiating tumour growth in immunodeficient mice","volume":"445","author":"O\u2019Brien","year":"2007","journal-title":"Nature"},{"key":"10.1038\/modpathol.2016.232_bib37","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/labinvest.2009.54","article-title":"Identification of CD44v6(+)\/CD24\u2212 breast carcinoma cells in primary human tumors by quantum dot-conjugated antibodies","volume":"89","author":"Snyder","year":"2009","journal-title":"Lab Invest"},{"key":"10.1038\/modpathol.2016.232_bib38","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1038\/nm.1791","article-title":"A method for quantifying normal human mammary epithelial stem cells with in vivo regenerative ability","volume":"14","author":"Eirew","year":"2008","journal-title":"Nat Med"},{"key":"10.1038\/modpathol.2016.232_bib39","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nature04496","article-title":"Purification and unique properties of mammary epithelial stem cells","volume":"439","author":"Stingl","year":"2006","journal-title":"Nature"},{"key":"10.1038\/modpathol.2016.232_bib40","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1083\/jcb.200611114","article-title":"Evidence for a stem cell hierarchy in the adult human breast","volume":"177","author":"Villadsen","year":"2007","journal-title":"J Cell Biol"},{"key":"10.1038\/modpathol.2016.232_bib41","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/ijc.23103","article-title":"Alpha-6 integrin is necessary for the tumourigenicity of a stem cell-like subpopulation within the MCF7 breast cancer cell line","volume":"122","author":"Cariati","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1038\/modpathol.2016.232_bib42","first-page":"901","article-title":"High expression level of alpha 6 integrin in human breast carcinoma is correlated with reduced survival","volume":"55","author":"Friedrichs","year":"1995","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2016.232_bib43","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/1471-2407-13-289","article-title":"Profiling of normal and malignant breast tissue show CD44high\/CD24low phenotype as a predominant stem\/progenitor marker when used in combination with Ep-CAM\/CD49f markers","volume":"13","author":"Ghebeh","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1038\/modpathol.2016.232_bib44","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ccr.2007.01.013","article-title":"Molecular definition of breast tumor heterogeneity","volume":"11","author":"Shipitsin","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1038\/modpathol.2016.232_bib45","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/stem.1075","article-title":"P-cadherin is co-expressed with Cd44 and Cd49f and mediates stem cell properties in basal-like breast cancer","volume":"30","author":"Vieira","year":"2012","journal-title":"Stem Cells"},{"key":"10.1038\/modpathol.2016.232_bib46","doi-asserted-by":"crossref","first-page":"679","DOI":"10.18632\/oncotarget.1459","article-title":"P-cadherin signals through the laminin receptor alpha6beta4 integrin to induce stem cell and invasive properties in basal-like breast cancer cells","volume":"5","author":"Vieira","year":"2014","journal-title":"Oncotarget"},{"key":"10.1038\/modpathol.2016.232_bib47","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/onc.2009.338","article-title":"Extracellular cleavage and shedding of P-cadherin: a mechanism underlying the invasive behaviour of breast cancer cells","volume":"29","author":"Ribeiro","year":"2010","journal-title":"Oncogene"},{"key":"10.1038\/modpathol.2016.232_bib48","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/path.4143","article-title":"P-cadherin functional role is dependent on E-cadherin cellular context: a proof of concept using the breast cancer model","volume":"229","author":"Ribeiro","year":"2013","journal-title":"J Pathol"},{"key":"10.1038\/modpathol.2016.232_bib49","doi-asserted-by":"crossref","first-page":"5869","DOI":"10.1158\/1078-0432.CCR-05-0059","article-title":"P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation","volume":"11","author":"Paredes","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2016.232_bib50","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/modpathol.3880367","article-title":"The prognostic significance of P-cadherin in infiltrating ductal breast carcinoma","volume":"14","author":"Gamallo","year":"2001","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2016.232_bib51","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s004280100487","article-title":"P-cadherin expression is associated with high-grade ductal carcinoma in situ of the breast","volume":"440","author":"Paredes","year":"2002","journal-title":"Virchows Arch"},{"key":"10.1038\/modpathol.2016.232_bib52","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/(SICI)1097-0142(19991001)86:7<1263::AID-CNCR23>3.0.CO;2-2","article-title":"P-cadherin expression in breast carcinoma indicates poor survival","volume":"86","author":"Peralta Soler","year":"1999","journal-title":"Cancer"},{"key":"10.1038\/modpathol.2016.232_bib53","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/modpathol.2010.189","article-title":"P-cadherin expression as a prognostic biomarker in a 3992 case tissue microarray series of breast cancer","volume":"24","author":"Turashvili","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2016.232_bib54","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00428-006-0334-y","article-title":"P-cadherin and cytokeratin 5: useful adjunct markers to distinguish basal-like ductal carcinomas in situ","volume":"450","author":"Paredes","year":"2007","journal-title":"Virchows Arch"},{"key":"10.1038\/modpathol.2016.232_bib55","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1158\/1078-0432.CCR-04-2064","article-title":"Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancer","volume":"11","author":"Arnes","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2016.232_bib56","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12943-015-0448-4","article-title":"P-cadherin and the journey to cancer metastasis","volume":"14","author":"Vieira","year":"2015","journal-title":"Mol Cancer"},{"key":"10.1038\/modpathol.2016.232_bib57","doi-asserted-by":"crossref","first-page":"v8","DOI":"10.1093\/annonc\/mdv298","article-title":"Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"26 Suppl 5","author":"Senkus","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1038\/modpathol.2016.232_bib58","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/jnci\/djp082","article-title":"Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer","volume":"101","author":"Cheang","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/modpathol.2016.232_bib59","first-page":"605","article-title":"Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathological features","volume":"146","author":"Palacios","year":"1995","journal-title":"Am J Pathol"},{"key":"10.1038\/modpathol.2016.232_bib60","first-page":"3606","article-title":"Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers","volume":"9","author":"Palacios","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2016.232_bib61","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/jcp.2011.090456","article-title":"Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype","volume":"64","author":"Ricardo","year":"2011","journal-title":"J Clin Pathol"},{"key":"10.1038\/modpathol.2016.232_bib62","first-page":"963","article-title":"P-cadherin, vimentin and CK14 for identification of basal-like phenotype in breast carcinomas: an immunohistochemical study","volume":"25","author":"Sousa","year":"2010","journal-title":"Histol Histopathol"},{"key":"10.1038\/modpathol.2016.232_bib63","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/bjc.1982.62","article-title":"A prognostic index in primary breast cancer","volume":"45","author":"Haybittle","year":"1982","journal-title":"Br J Cancer"},{"key":"10.1038\/modpathol.2016.232_bib64","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1053\/ejso.2002.1259","article-title":"EGFR c-erbB2 and p53 protein in the primary lesions and paired metastatic regional lymph nodes in breast cancer","volume":"28","author":"Tsutsui","year":"2002","journal-title":"Eur J Surg Oncol"},{"key":"10.1038\/modpathol.2016.232_bib65","doi-asserted-by":"crossref","first-page":"9233","DOI":"10.7314\/APJCP.2014.15.21.9233","article-title":"Alterations in hormonal receptor expression and HER2 status between primary breast tumors and paired nodal metastases: discordance rates and prognosis","volume":"15","author":"Ba","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1038\/modpathol.2016.232_bib66","doi-asserted-by":"crossref","first-page":"228","DOI":"10.5114\/pjp.2012.32769","article-title":"Expression of ER\/PR\/HER2, basal markers and adhesion molecules in primary breast cancer and in lymph nodes metastases: a comparative immunohistochemical analysis","volume":"63","author":"Adamczyk","year":"2012","journal-title":"Pol J Pathol"},{"key":"10.1038\/modpathol.2016.232_bib67","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2217\/bmm.15.123","article-title":"Survival of breast cancer patients according to changes in expression of selected markers between primary tumor and lymph node metastases","volume":"10","author":"Adamczyk","year":"2016","journal-title":"Biomark Med"},{"key":"10.1038\/modpathol.2016.232_bib68","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10549-015-3406-3","article-title":"Markers of progression in early-stage invasive breast cancer: a predictive immunohistochemical panel algorithm for distant recurrence risk stratification","volume":"151","author":"Aleskandarany","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"10.1038\/modpathol.2016.232_bib69","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s10549-009-0674-9","article-title":"An online survival analysis tool to rapidly assess the effect of 22 277 genes on breast cancer prognosis using microarray data of 1809 patients","volume":"123","author":"Gyorffy","year":"2010","journal-title":"Breast Cancer Res Treat"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol2016232.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2016232","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222022293?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222022293?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/modpathol.2016.232","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2016232.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:57:56Z","timestamp":1760230676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222022293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":69,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0893395222022293"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2016.232","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"P-cadherin: a useful biomarker for axillary-based breast cancer decisions in the clinical practice","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2016.232","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}